Enabling Precision Medicine The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop (2017) / Chapter Skim
Currently Skimming:
Appendix D: Registered Attendees
Appendix D: Registered Attendees
Pages 117-122
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 117... ...
Naomi Aronson Khaled Bouri Blue Cross and Blue Shield U.S. Food and Drug Administration Association Linda Brady Christopher Austin National Institutes of Health National Institutes of Health 117
|
From page 118... ...
Food and Drug Administration Tamara Darsow Jonca Bull American Diabetes Association U.S. Food and Drug Administration Claude Desjardins Esteban Burchard Johns Hopkins University University of California, San Francisco Michael Dougherty American Society of Human Robert Califf Genetics Duke University Lee Dudka Karim Calis SyTrue National Institutes of Health Helena Duncan John Carulli College of American Pathologists Biogen Georgia Dunston Ann Cashion Howard University National Institute of Nursing Research Marni Falk Children's Hospital of Philadelphia Scott Chandler Genentech/Roche Michael Farkouh University of Toronto Henry Chang National Institutes of Health Greg Feero Journal of the American Medical Aparna Chhibber Association Merck & Co., Inc.
|
From page 119... ...
Syapse Taylor Gilliland Lyric Jorgenson National Center for Advancing National Institutes of Health Translational Sciences Thea Kalebic Geoffrey Ginsburg Takeda Duke University Cheryl Kassed Jill Hagenkord IQ Solutions Color Genomics Rusty Kelley Roy Herbst Burroughs Wellcome Fund Yale School of Medicine Amy Kennedy Dennis Holl National Cancer Institute Zachary Hornby Muin Khoury Ignyta Centers for Disease Control and Prevention Xiaolan Hu Consultant Oliver Kim Mousetrap Lynn Hudson Critical Path Institute Roger Klein Nina Hunter Elena Koustova U.S. Food and Drug Administration National Institute on Drug Abuse Chazeman Jackson David Lanfear U.S.
|
From page 120... ...
Translational Sciences Matthew Nelson Michelle Lowes GlaxoSmithKline The Rockefeller University Laura Nisenbaum Julie Lynch Eli Lilly and Company Salt Lake City Veterans Affairs Medical Center Robert Nussbaum Invitae Patrick Mahoney National Cancer Institute Sam Oh University of California, San Saralyn Mark Francisco National Aeronautics and Space Administration Alexander Ommaya Association of American Medical Sarah Martin Colleges American Association for Cancer Research Ward Ortmann Genentech David McCann National Institute on Drug Abuse
|
From page 121... ...
Pratt Jessica Scott Association for Molecular Pathology GlaxoSmithKline Angela Qu Joan Scott Parexel Health Resources and Services Administration Anuradha Ramamoorthy U.S. Food and Drug Administration Roza Selimyan University of Maryland University Rajadhar Reddy College National Academy of Medicine Geetha Senthil Sanjana Reddy National Institute of Mental U.S.
|
From page 122... ...
Mark Stewart Friends of Cancer Research Scott Weinberg American Medical Informatics Theresa Strong Association Foundation for Prader-Willi Research David Wierz The OCI Group Jielin Sun U.S. Food and Drug Administration Bob Wildin National Human Genome Margaret Sutherland Research Institute National Institute of Neurological Disorders and Stroke Janet Williams American Academy of Nursing Betty Tai National Institute on Drug Abuse L
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.